Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1257381-44-4

Post Buying Request

1257381-44-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1257381-44-4 Usage

General Description

2-oxa-7-azaspiro[3.5]nonane 2,2,2-trifluoroacetate is a chemical compound with the molecular formula C9H15F3NO3. It is a spirocyclic compound that contains a seven-membered ring with one oxygen and one nitrogen atom. The compound is also bound to a 2,2,2-trifluoroacetate group, which consists of three fluorine atoms attached to a central carbon atom. 2-oxa-7-azaspiro[3.5]nonane 2,2,2-trifluoroacetate is used in organic chemistry and pharmaceutical research as a building block for the synthesis of more complex molecules. It has potential applications in drug discovery and development due to its unique structure and properties.

Check Digit Verification of cas no

The CAS Registry Mumber 1257381-44-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,5,7,3,8 and 1 respectively; the second part has 2 digits, 4 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1257381-44:
(9*1)+(8*2)+(7*5)+(6*7)+(5*3)+(4*8)+(3*1)+(2*4)+(1*4)=164
164 % 10 = 4
So 1257381-44-4 is a valid CAS Registry Number.

1257381-44-4Downstream Products

1257381-44-4Relevant articles and documents

SUBSTITUTED PYRIDINE DERIVATIVES AS FABI INHIBITORS

-

Page/Page column 105, (2013/06/27)

The present invention provides substituted pyridine derivatives of formula (I), which may be therapeutically useful as as anti-bacterial agents, more particulalrly FabI inhibitors. Formula(I) in which R1 to R5 and L have the meanings given in the specification, and pharmaceutically acceptable salts thereof that are useful in the treatment and prevention in diseases or disorder, in particular their use in diseases or disorder where there is an advantage anti-bacterial agents, more particularly FabI inhibitors. The present invention also provides methods for synthesizing and administering the FabI inhibitor compounds. The present invention also provides pharmaceutical formulations comprising at least one of the FabI inhibitor compounds together with a pharmaceutically acceptable carrier, diluent or excipient therefor.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1257381-44-4